Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

AI Specialist Veritone Soars on Major Contract Wins and Upbeat Forecast

Dieter Jaworski by Dieter Jaworski
October 15, 2025
in AI & Quantum Computing, Earnings, Nasdaq, Tech & Software, Trading & Momentum
0
Veritone Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Veritone shares experienced a dramatic surge in after-hours trading following the announcement of substantial new contracts for its Data Refinery platform and an improved quarterly outlook. The stock skyrocketed 26.55% to $6.91, building significantly on the previous day’s advance of 9.64%.

Financial Performance and Market Reaction

The company released preliminary third-quarter results alongside its contract news, projecting revenue between $28.5 million and $28.7 million. This represents impressive growth of approximately 30.5% compared to the same period last year. While Veritone continues to anticipate an adjusted net loss ranging from $5.5 million to $6.0 million, this forecast shows modest improvement over previous guidance of $6.0 million to $6.5 million. The combination of robust revenue expansion, reduced projected losses, and major contract achievements fueled substantial investor optimism, reflected in the powerful after-hours rally.

Should investors sell immediately? Or is it worth buying Veritone?

Contract Momentum Drives Growth

Central to the bullish sentiment was Veritone’s disclosure of major agreements for its VDR solution. These recent contracts have propelled the company’s short-term pipeline and recent bookings to approximately $40 million, representing a dramatic doubling since August 2025. The Data Refinery platform specializes in converting unstructured data into actionable intelligence for training artificial intelligence models. Chief Executive Ryan Steelberg highlighted the company’s accelerating momentum, indicating that Veritone expects to formalize partnerships with nearly all major hyperscale cloud providers by the end of 2025.

Upcoming Catalyst in Focus

Market attention now turns to November 6, when Veritone will report complete third-quarter financial results. The critical test for the company will be demonstrating its capacity to convert the expanding Data Refinery pipeline into sustained revenue growth while continuing to narrow its losses. The current substantial share price movement indicates strong market approval of both the strategic contract victories and the improving financial trajectory for this artificial intelligence solutions provider.

Ad

Veritone Stock: Buy or Sell?! New Veritone Analysis from February 7 delivers the answer:

The latest Veritone figures speak for themselves: Urgent action needed for Veritone investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Veritone: Buy or sell? Read more here...

Tags: Veritone
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
Corning Stock

Corning's Strategic Pivot Positions It for AI and Electric Vehicle Expansion

Thermo Fisher Scientific Stock

Wall Street Bullish on Thermo Fisher's Growth Trajectory

Broadcom Stock

Broadcom Emerges as Silent Powerhouse in Booming AI Hardware Sector

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com